{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:18:50Z","timestamp":1794277130273,"version":"4.9.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400583"],"award-info":[{"award-number":["32400583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32450786"],"award-info":[{"award-number":["32450786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tongji Hospital Clinical Research Flagship Program Funding","award":["2019CR206"],"award-info":[{"award-number":["2019CR206"]}],"id":[{"id":"https:\/\/ror.org\/04xy45965","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Tongji Hospital High-Quality Clinical Research Funding","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}],"id":[{"id":"https:\/\/ror.org\/04xy45965","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03743-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:23:31Z","timestamp":1769685811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reassessing the role of watchful waiting strategy for IgG4-related disease: a real-world study"],"prefix":"10.1186","volume":"28","author":[{"given":"Chengqian","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilian","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"3743_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol Engl. 2012;22:21\u201330. https:\/\/doi.org\/10.1007\/s10165-011-0571-z.","journal-title":"Mod Rheumatol Engl"},{"key":"3743_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16:702\u201314. https:\/\/doi.org\/10.1038\/s41584-020-0500-7.","journal-title":"Nat Rev Rheumatol"},{"key":"3743_CR3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206605.","journal-title":"Ann Rheum Dis"},{"key":"3743_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409712","author":"JH Stone","year":"2024","unstructured":"Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, et al. Inebilizumab for treatment of IgG4-Related disease. N Engl J Med [Internet]. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2409712.","journal-title":"N Engl J Med [Internet]"},{"key":"3743_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","volume":"73","author":"G Katz","year":"2022","unstructured":"Katz G, Stone JH. Clinical perspectives on IgG4-Related disease and its classification. Annu Rev Med. 2022;73:545\u201362. https:\/\/doi.org\/10.1146\/annurev-med-050219-034449.","journal-title":"Annu Rev Med"},{"key":"3743_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.01.033","author":"Y Chen","year":"2025","unstructured":"Chen Y, Ye C, Yang P, Zhang W, Dai L, Wei W, et al. Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study. Ann Rheum Dis [Internet]. 2025. https:\/\/doi.org\/10.1016\/j.ard.2025.01.033.","journal-title":"Ann Rheum Dis [Internet]"},{"key":"3743_CR7","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.gie.2007.06.059","volume":"66","author":"K Kubota","year":"2007","unstructured":"Kubota K, Iida H, Fujisawa T, Yoneda M, Inamori M, Abe Y, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142\u201351. https:\/\/doi.org\/10.1016\/j.gie.2007.06.059.","journal-title":"Gastrointest Endosc"},{"key":"3743_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-Related disease. Arthritis Rheumatol. 2015;67:1688\u201399. https:\/\/doi.org\/10.1002\/art.39132.","journal-title":"Arthritis Rheumatol"},{"key":"3743_CR9","doi-asserted-by":"publisher","first-page":"e000295","DOI":"10.1136\/bmjophth-2019-000295","volume":"4","author":"J Ominato","year":"2019","unstructured":"Ominato J, Oyama T, Cho H, Shiozaki N, Umezu H, Takizawa J, et al. The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study. BMJ Open Ophth. 2019;4:e000295. https:\/\/doi.org\/10.1136\/bmjophth-2019-000295.","journal-title":"BMJ Open Ophth"},{"key":"3743_CR10","doi-asserted-by":"publisher","unstructured":"Kuo H-H, Chen C-H, Wu S-Y. Debulking Surgery Combined with Low-Dose Oral Prednisolone and Azathioprine for Intractable IgG4-Related Orbital Disease: A Case Report. Medicina (Kaunas). Switzerland; 2021;57. https:\/\/doi.org\/10.3390\/medicina57050448.","DOI":"10.3390\/medicina57050448"},{"key":"3743_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/01658107.2020.1729817","volume":"45","author":"Y Hamano","year":"2021","unstructured":"Hamano Y, Kitaguchi Y, Nishida K. Corticosteroid withdrawal after complete resection of recurrent IgG4-Related ophthalmic disease. Neuro-Ophthalmology. 2021;45:184\u20138. https:\/\/doi.org\/10.1080\/01658107.2020.1729817.","journal-title":"Neuro-Ophthalmology"},{"key":"3743_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire J-F, et al. The 2019 American college of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77\u201387. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216561.","journal-title":"Ann Rheum Dis"},{"key":"3743_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol. 2012;2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/259408.","journal-title":"Int J Rheumatol"},{"key":"3743_CR14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.23543","volume":"70","author":"ZS Wallace","year":"2018","unstructured":"Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, et al. An international multispecialty validation study of the IgG4-Related disease responder index. Arthritis Care Res. 2018;70:1671\u20138. https:\/\/doi.org\/10.1002\/acr.23543.","journal-title":"Arthritis Care Res"},{"key":"3743_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7861\/clinmedicine.15-4-396","volume":"15","author":"VBP Ramasamy","year":"2015","unstructured":"Ramasamy VBP, Trefor R, Rajamani K, Santosh D, Griffiths D, Donovan K. Lesson of the month 2: IgG4-related renal mass with spontaneous resolution. Clin Med (Lond) Engl. 2015;15:396\u20138. https:\/\/doi.org\/10.7861\/clinmedicine.15-4-396.","journal-title":"Clin Med (Lond) Engl"},{"key":"3743_CR16","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1016\/j.amjmed.2022.06.004","volume":"135","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Jaafar R, Misron NA, Yusof Z. IgG4-Related disease of the pharynx with spontaneous regression. Am J Med. 2022;135:e420\u20132. https:\/\/doi.org\/10.1016\/j.amjmed.2022.06.004.","journal-title":"Am J Med"},{"key":"3743_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jhbp.541","volume":"25","author":"K Kubota","year":"2018","unstructured":"Kubota K, Kamisawa T, Hirano K, Hirooka Y, Uchida K, Ikeura T, et al. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients. J Hepatobiliary Pancreat Sci. 2018;25:223\u201330. https:\/\/doi.org\/10.1002\/jhbp.541.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3743_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2169\/internalmedicine.56.7996","volume":"56","author":"H Yamakawa","year":"2017","unstructured":"Yamakawa H, Sekine A, Yamanaka Y, Sadoyama S, Baba T, Hagiwara E, et al. Pathologically proven spontaneous remission of IgG4-related retroperitoneal fibrosis. Intern Med. 2017;56:1867\u201371. https:\/\/doi.org\/10.2169\/internalmedicine.56.7996.","journal-title":"Intern Med"},{"key":"3743_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/bjophthalmol-2018-313730","volume":"104","author":"T Kubota","year":"2020","unstructured":"Kubota T, Katayama M, Nishimura R, Moritani S. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease. Br J Ophthalmol Engl. 2020;104:345\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313730.","journal-title":"Br J Ophthalmol Engl"},{"key":"3743_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13075-022-02792-z","volume":"24","author":"J Zongfei","year":"2022","unstructured":"Zongfei J, Lingli C, Ying S, Lingying M, Lijuan Z, Dongmei L, et al. Clinical and pathological predictors of relapse in IgG4-related disease. Arthritis Res Ther. 2022;24:106. https:\/\/doi.org\/10.1186\/s13075-022-02792-z.","journal-title":"Arthritis Res Ther"},{"key":"3743_CR21","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1136\/gut.2006.115246","volume":"56","author":"K Hirano","year":"2007","unstructured":"Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719\u201324.","journal-title":"Gut"},{"key":"3743_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","volume":"52","author":"Y Shimizu","year":"2013","unstructured":"Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, et al. Necessity of early intervention for IgG4-related disease\u2013delayed treatment induces fibrosis progression. Rheumatology (Oxford). 2013;52:679\u201383. https:\/\/doi.org\/10.1093\/rheumatology\/kes358.","journal-title":"Rheumatology (Oxford)"},{"key":"3743_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song Y, Li J, Wu Y. Evolving Understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Sig Transduct Target Ther. 2024;9:263. https:\/\/doi.org\/10.1038\/s41392-024-01952-8.","journal-title":"Sig Transduct Target Ther"},{"key":"3743_CR24","doi-asserted-by":"publisher","first-page":"m1067","DOI":"10.1136\/bmj.m1067","volume":"369","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. Br Med J Publishing Group. 2020;369:m1067. https:\/\/doi.org\/10.1136\/bmj.m1067.","journal-title":"Br Med J Publishing Group"},{"key":"3743_CR25","doi-asserted-by":"publisher","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","volume":"95","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: A systematic review. Med (Baltimore) United States. 2016;95:e4002. https:\/\/doi.org\/10.1097\/MD.0000000000004002.","journal-title":"Med (Baltimore) United States"},{"key":"3743_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40744-025-00763-9","volume":"12","author":"ZS Wallace","year":"2025","unstructured":"Wallace ZS, Park JY, Serra E, Gagnon-Sanschagrin P, Gu\u00e9rin A, Patterson K, et al. Burden of glucocorticoid use and risk of toxicities among patients with Immunoglobulin-G4-Related disease: A retrospective US-Based claims study. Rheumatol Ther Engl. 2025;12:547\u201360. https:\/\/doi.org\/10.1007\/s40744-025-00763-9.","journal-title":"Rheumatol Ther Engl"},{"key":"3743_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/rheumatology\/kez280","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xue M, Wang Z, Zeng Q, Ren L, Zhang Y, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatol (Oxford) Engl. 2020;59:634\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kez280.","journal-title":"Rheumatol (Oxford) Engl"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03743-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03743-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03743-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:35:21Z","timestamp":1771598121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03743-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3743"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03743-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board and Medical Ethics Committee of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (TJ-IRB202404090).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}